OOIR: Observatory of International Research

Papers

(The TQCC of Acta Haematologica is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Treating Leukemia in the Time of COVID-19	44
Systematic Review of Microthrombi in COVID-19 Autopsies	33
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic	26
Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019	26
Accelerated Phase of Myeloproliferative Neoplasms	26
Hematological Manifestations among Patients with Rheumatic Diseases	21
The Association between Metabolic Syndrome and Multiple Myeloma	18
COVID-19 Coagulopathy: From Pathogenesis to Treatment	18
Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective	17
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations	15
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel	15
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?	15
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia an	13
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs	13
JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients	12
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis	11
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant	10
Adherence to Immunization: Rebuttal of Vaccine Hesitancy	10
Perspective: SARS-CoV-2, COVID-19 and Haematologists	10
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?	9
ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report	9
Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy	9
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma	9
<b><i>BCR/ABL1</i></b>-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy	8
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response	8

Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?	8
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm	8
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy	8
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk	8
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids	7
Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine	7
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment	7
Vaccination for SARS-CoV-2 in Hematological Patients	7
Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience	7
Current and Emerging Treatments for Waldenström Macroglobulinemia	7
Viscoelastic Coagulation Monitor (VCM<sup>Vet</sup>) Reference Intervals and Sex Differences in Mature Adult Mice	6
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Ac	6
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review	6
A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination	6
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments	6
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients	6
Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy	6
Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma	6
Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation	6
Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity	6
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A	5
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia	5
Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic Thrombocytopenic Purpura	5
Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia	5
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series	4
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis	4
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry	4
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype	4
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation	4
Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies	4
Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review	4
Efficacy of Individualized Preventive Treatment of Patients with Severe Hemophilia A Guided by Multiple Clinical Parameters and Pharmacokinetics	4
Eltrombopag for the Treatment of Severe Inherited Thrombocytopenia	4
<b><i>DIAPH1</i></b> Mutation as a Novel Cause of Autosomal Dominant Macrothrombocytopenia and Hearing Loss	4
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune Thrombocytopenia	4
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation	4
Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review	4
Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19	4
Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience	4
Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor	4
How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?	4
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?	4
Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas	4
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients	4
Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma	3
Use of Core-Needle Biopsy for the Diagnosis of Malignant Lymphomas in Clinical Practice	3
PNH Clones for Aplastic Anemia with Immunosuppressive Therapy: A Systematic Review and Meta-Analysis	3
Survival Disparities in Multiple Myeloma by Health Insurance Status among US Non-Elderly Adults: A SEER-Based Comparative Analysis	3
Effects of Glycosaminoglycan from <b><i>Urechis unicinctus</i></b> on ADP-Induced Platelet Calcium and Membrane Glycoprotein Expressions in Rats	3
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes	3

Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma	3
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature	3
Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Contr	3
Association between Platelet-Associated Immunoglobulin G Levels and Response to Corticosteroid Therapy in Patients with Newly Diagnosed Immune Thrombocytopenia	3
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-	3
Chronic Eosinophilic Leukaemia Associated with <b><i>JAK2</i></b> Exon 13 Insertion/Deletion Mutations	3
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient	3
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa	3
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response	3
Significance of the p.Phe218Ser and p.Gly304Glu F5 Variants in Hereditary Factor V Deficiency	3
STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma	3
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia	3
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling	3
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer	3
Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse	3
Prognostic Markers in the Era of Targeted Therapies	3
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study	3